BioWorld-International-2011-10-05
Creabilis Raises $20M in Series B to Advance Psoriasis Drug
Creabilis Raises $20M in Series B to Advance Psoriasis Drug
Creabilis S.A. raised €15 million (US$20 million) in a Series B round to advance a pipeline of three compounds in development for dermatology, inflammation and pain indications. (BioWorld International)

